Artivion Inc

CYL

Company Profile

  • Business description

    Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company’s products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

  • Contact

    1655 Roberts Boulevard North West
    KennesawGA30144
    USA

    T: +1 770 419-3355

    E: investors@artivion.com

    https://www.artivion.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    1,600

Stocks News & Analysis

stocks

Ask the analyst: Are IDP Education's woes temporary?

The global education services provider has gone from stock market darling to one of the ASX's weakest performers. What gives?
stocks

Is it time to buy the Magnificent Seven?

After the recent selloff, the bull market’s most in-demand stocks look much cheaper.
stocks

Chart of the week: Did ASX companies underwhelm or impress during earnings season?

The Chart of the Week looks at how our Fair Values changes for Australian companies during earnings season.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change

Market Movers